As of June 30, 2026, Instituto de Diagnostico S.A. has 144.60M shares outstanding.
| Shares Outstanding | 144.60M |
As of June 30, 2026, Instituto de Diagnostico S.A. maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 55.78, indicating elevated leverage, while an interest coverage ratio of 3.36 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.98 |
| Quick Ratio | 0.10 |
| Debt / Equity | 55.78 |
| Debt / EBITDA | 5.14 |
| Interest Coverage | 3.36 |
Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. posted a return on equity (ROE) of 7.51, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 3.38, measuring how efficiently the asset base is converted into earnings. The company generates approximately 100,813.32 in revenue per employee across its workforce of 3,071.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 68.98 indicates how many times Instituto de Diagnostico S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 7.51 |
| Return on Assets (ROA) | 3.38 |
| Revenue Per Employee | 100,813.32 |
| Employee Count | 3,071.00 |
| Inventory Turnover | 68.98 |
Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. recorded an income tax benefit of -464,776.97 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 13.21M, leaving 13.68M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -464,776.97 |
Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. generated 309.60M in revenue and converted that into 13.68M in net income, yielding earnings per share of 0.09. EBITDA reached 26.21M, while operating income came in at 16.03M.
| Revenue | 309.60M |
| Gross Profit | 80.21M |
| Operating Income | 16.03M |
| Pretax Income | 13.21M |
| Net Income | 13.68M |
| EBITDA | 26.21M |
| EBIT | 16.03M |
| Earnings Per Share (EPS) | 0.09 |
As of June 30, 2026, Instituto de Diagnostico S.A. holds 13.31M in cash and equivalents against 134.57M in total debt, resulting in a net debt position of 106.78M. Total book value stands at 241.25M, with working capital of -2.58M providing operational flexibility.
| Cash & Cash Equivalents | 13.31M |
| Total Debt | 134.57M |
| Net Debt | 106.78M |
| Equity (Book Value) | 241.25M |
| Book Value Per Share | 1.67 |
| Working Capital | -2.58M |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -7.13M |
Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. posted a gross margin of 25.91, reflecting its pricing power and cost economics. The operating margin of 5.18 and net profit margin of 4.42 provide insight into operational efficiency.
| Gross Margin | 25.91 |
| Operating Margin | 5.18 |
| Pretax Margin | 4.27 |
| Profit Margin | 4.42 |
| EBITDA Margin | 8.46 |
Instituto de Diagnostico S.A.'s most recent stock split took place on September 10, 2025.
| Last Split Date | 9/10/2025 |
Already premium?